- Statements and Press Releases
Facilitating Platform Clinical Trials During Global Public Health Emergencies (November 2024)
Fostering regulatory collaboration to improve access to mpox medicines (October 2024)
ICH reflection paper on integrating real-world evidence into regulatory decision-making (July 2023)
ICMRA receives ‘Global Award for Outstanding Contribution to Health’ at DIA 2023 (July 2023)
ICMRA PQKMS Collaborative Pilot - Call for Industry Applications (June 2022)
Antimicrobial Resistance Statement (July 2019)
Antimicrobial Resistance Statement (French)
Antimicrobial Resistance Statement (Portuguese)
Antimicrobial Resistance Statement (Spanish)ICMRA statement about confidence in biosimilar products (for healthcare professionals) (July 2019)
ICMRA statement about confidence in biosimilar products (for patients and the public) (July 2019)